An exploratory comparative case series of calcitonin gene-related peptide monoclonal antibodies in patients with migraine with rosacea

被引：2
|
作者：
Sia, Twan [1 ]
Webb, Taylor [1 ]
Li, Shufeng [1 ,2 ]
Moskatel, Leon S. [3 ]
Chang, Anne Lynn S. [1 ]
机构：
[1] Stanford Univ, Sch Med, Dept Dermatol, Redwood City, CA 94063 USA
[2] Stanford Univ, Sch Med, Dept Urol, Acad Med Ctr, Palo Alto, CA USA
[3] Stanford Hlth Care, Dept Neurol & Neurol Sci, Stanford, CA USA
来源：
BRITISH JOURNAL OF DERMATOLOGY | 2023年 / 189卷 / 06期
关键词：
D O I：
10.1093/bjd/ljad277
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
[No abstract available]
引用
收藏
页码：776 / 778
页数：3
相关论文
共 50 条
  • [21] Anti-Calcitonin Gene-Related Peptide Monoclonal Antibodies in Migraine: Focus on Drug Interactions
    Jankovic, Slobodan M.
    Jankovic, Snezana V.
    EUROPEAN JOURNAL OF DRUG METABOLISM AND PHARMACOKINETICS, 2024, 49 (03) : 263 - 275
  • [22] New Trends in Migraine Pharmacology: Targeting Calcitonin Gene-Related Peptide (CGRP) With Monoclonal Antibodies
    Scuteri, Damiana
    Adornetto, Annagrazia
    Rombola, Laura
    Naturale, Maria Diana
    Morrone, Luigi Antonio
    Bagetta, Giacinto
    Tonin, Paolo
    Corasaniti, Maria ziana
    FRONTIERS IN PHARMACOLOGY, 2019, 10
  • [23] Can calcitonin gene-related peptide monoclonal antibodies ameliorate writer's cramp and migraine?
    Suzuki, Keisuke
    Suzuki, Shiho
    Fujita, Hiroaki
    Sakuramoto, Hirotaka
    Shioda, Mukuto
    Hirata, Koichi
    NEUROPSYCHOPHARMACOLOGY REPORTS, 2024, 44 (02) : 482 - 484
  • [24] Anti-calcitonin Gene-Related Peptide Monoclonal Antibodies in Migraine: Focus on Clinical Pharmacokinetics
    Jankovic, Slobodan M.
    Jankovic, Snezana V.
    EUROPEAN JOURNAL OF DRUG METABOLISM AND PHARMACOKINETICS, 2024, 49 (03) : 277 - 293
  • [25] Use of Anti-calcitonin Gene-Related Peptide Monoclonal Antibodies in Pediatric Migraine Prevention
    Suleman, Saher
    Chow, Clara
    Rastogi, Reena Gogia
    NEUROLOGY, 2021, 96 (15)
  • [26] Adherence and Persistence of Calcitonin Gene-Related Peptide Monoclonal Antibodies in Patients with Migraine: A Real-World Study
    Varnado, O.
    Brady, L.
    Zagar, A.
    Robles, Y.
    Hoyt, M.
    Hall, J.
    HEADACHE, 2023, 63 : 184 - 184
  • [27] Adherence and Persistence of Calcitonin Gene-Related Peptide Monoclonal Antibodies in Patients with Migraine: A Real-World Study
    Varnado, Oralee
    Brady, Brenna
    Zagar, Anthony J.
    Robles, Yvonne
    Hoyt, Margaret
    Hall, Jerry
    NEUROLOGY, 2023, 100 (17)
  • [28] Persistence, effectiveness, and tolerability of anti-calcitonin gene-related peptide monoclonal antibodies in patients with chronic migraine
    de Dios, Anna
    Pages-Puigdemont, Neus
    Ojeda, Sergio
    Riera, Pau
    Pelegrin, Rebeca
    Morollon, Noemi
    Belvis, Robert
    Real, Jordi
    Masip, Montserrat
    HEADACHE, 2025, 65 (01): : 24 - 34
  • [29] CALCITONIN GENE-RELATED PEPTIDE MONOCLONAL ANTIBODY THERAPY IN PATIENTS WITH MIGRAINE AND COMORBID COMPLEX REGIONAL PAIN SYNDROME: A CASE SERIES
    Smith, Jonathan
    MUSCLE & NERVE, 2020, 62 : S45 - S45
  • [30] Treatment of hemiplegic migraine with anti-calcitonin gene-related peptide monoclonal antibodies: A case series in a tertiary-care headache center
    Danno, Daisuke
    Ishizaki, Kumiko
    Kikui, Shoji
    Takeshima, Takao
    HEADACHE, 2023, 63 (07): : 984 - 989
12345